A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

Inflammation has to fight pathogens fast—but it can't get out of control. Researchers at the German Cancer Research Center ...

Treatment with nivolumab (Opdivo) had limited benefit in patients with multiple myeloma (MM) or non-Hodkin lymphoma (NHL) ...

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...

Researchers at the University of Southampton engineered four-pronged antibodies that cluster the CD27 immune receptor, strongly activating cancer-killing T cells.

Scientists found that nasal cells act as a first line of defense against the common cold, working together to block ...

The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules.

Initial results as promising as those in lupus and other non-cancer diseases driven by B c ...

Each immune cell group has distinct metabolic requirements, activation pathways, and cytokine reliance. Standard, one-size-fits-all media cannot address these features. When studying diverse cell ...

Cells that are about to die send a signal to an executioner protein, but sometimes, those cells can fight back and regenerate ...